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Background and Purpose:  Multiple sclerosis (MS) in Asians is characterized by frequent involvement of the 
spinal cord and optic nerve and low prevalence rates, but even the most fundamental epidemiologic findings and 
unique clinical features of MS patients in Korea have not been studied extensively. We performed this study to 
establish the clinical spectrum of MS patients in Korea.
Methods: Sixty-two MS patients (25 men and 37 women) who satisfied the diagnostic criteria for definite MS 
were reviewed retrospectively using medical records from two university hospitals and one general hospital. The MS 
patients were classified into the three clinical subtypes according to the involved site (opticospinal, spinal, and 
conventional MS).
Results: T h e  a g e  a t  M S  o n s e t  w a s  3 5 . 2 ± 1 3 . 3  ( m e a n ± S D )  y e a r s ,  a n d  t h e  p r e dominant  initial  clinical 
manifestations were myelopathy (54.8%) and optic neuropathy (33.9%). The single most common involved lesion site 
was the spinal cord (35.5%). Spinal (35.5%) and opticospinal (25.8%) MS were the most common type, and they 
had a frequent relapsing-remitting course and long lesions extending over two vertebral segments (as assessed 
using spinal cord MRI). The interval between the first symptom and relapse was 35.6±71.1 months, and the number 
of relapses was 3.8±2.6. The spinal form of MS was associated with a higher age at onset and a higher male-to- 
female ratio than the other types. Positive rates of CSF oligoclonal bands and IgG index and the number of patients 
with characteristic brain MRI lesions were low. However, the abnormal rate of visual evoked potentials was relatively 
high (64.4%).
Conclusion: The clinical features of MS patients in Korea are different from those in Western patients, but similar 
to those in Far East Asian patients. The value of the various diagnostic tools used for MS should therefore be 
reevaluated, at least for Korean patients.
J Clin Neurol 2(4):231-237, 2006
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INTRODUCTION
Multiple sclerosis (MS) is considered to be clinically 
heterogeneous. The prevalence of MS varies con-
siderably both geographically and ethnically worldwide: 
it is 30-80 per 100,000 in Canada, northern Europe, and 
the northern United States; 6-14 per 100,000 in the 
southern United States and southern Europe; and less 
than 1 per 100,000 in equatorial areas.
1,2 Many studies 
into MS have thus been carried out in Western countries. 
In Asians, MS is characterized by a lower prevalence, Journal of Clinical Neurology: Vol. 2, No. 4, 2006
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more frequent involvement of the optic nerve and spinal 
cord, and rare familial occurrence.
3-6 However, as a 
result of the low prevalence and high migration rate, not 
even the most fundamental epidemiologic and large 
clinical studies have been performed in Korea.
6 
Furthermore, there are no specific pathognomic clinical 
findings or highly sensitive and specific laboratory tools 
for the diagnosis of MS. In many cases, a long-term 
follow-up period is needed to confirm the diagnosis. The 
aim of this study was to establish whether there are any 
distinctive features of MS among Korean patients that 
distinguish it from those observed in Western and other 
Asian countries.
MATERIALS AND METHODS
We included all patients with definite MS who were 
diagnosed by the criteria of either Poser et al.
7 or 
McDonald et al.
8 They were recruited between January 
1987 and December 2004 from two tertiary referral 
university hospitals and one general hospital located in 
Chungcheong province, which is situated in the central 
area of South Korea. Patients with “possible” MS 
according to the criteria of McDonald et al.,
8 and those 
with “probable” MS according to the criteria of Poser et 
al.
7 were excluded from the study. The data from 62 
consecutive and unrelated patients (25 men and 37 
women) were included in the final analysis. The hospital 
records regarding their clinical symptoms, disease 
courses, neurological examinations, laboratory findings, 
and imaging studies were reviewed retrospectively.
The MS patients were classified into the three clinical 
subtypes according to the involved site. Those patients 
whose clinically estimated lesions were confined to the 
optic nerves and spinal cord were classified as having 
opticospinal MS. These patients could have minor 
brainstem signs, such as transient diplopia, nystagmus, 
and vertigo. Those who showed only spinal cord 
involvement at different levels and different times were 
classified as having the spinal form of MS. Patients with 
lesions at classical multiple sites in the CNS, including 
the cerebrum, cerebellum, and brainstem, were regarded 
as having conventional MS.
Descriptive analysis was performed for all variables in 
the data set. Qualitative variables are described by 
counts and percentages, while quantitative variables are 
described by means and standard deviations. Statistical 
analyses of the clinical and laboratory parameters among 
the subtypes of MS were performed using ANOVA and 
the chi-square test. A probability value of p<0.05 was 
considered statistically significant.
RESULTS
The patients comprised 25 men and 37 women whose 
age at disease onset was 35.2±13.3 years. The age 
distribution of symptom onset showed that MS occurs 
mainly in relatively young adults (Table 1). Familial 
occurrence of MS was not reported in all patients. Out 
of 62 patients, 57 (91.9%) had clinically definite MS, 
and the remaining five patients (8.1%) had laboratory- 
supported definite MS, as assessed using the criteria of 
Poser et al.
7 Among the 57 patients with clinically 
definite MS, 55 had experienced more than 2 attacks 
and had clinical evidence of 2 separate lesions (A1). 
Five patients with laboratory-supported definite MS had 
one attack, clinical evidence of one lesion, paraclinical 
evidence of another, separate lesion, and positive CSF 
oligoclonal band/IgG (B3). The 62 patients could also be 
classified into first category patients (n=57, 91.9%) and 
patients with monosymptomatic presentation (n=5, 8.1%) 
according to the criteria of McDonald et al.
8
The dominant first clinical manifestations originated 
as a result of myelopathy (54.8%) and optic neuropathy 
(33.9%; Table 2). Other symptoms or signs were related 
to brainstem involvement. Symptoms suggestive of 
lesions in the cerebral white matter or the cerebellum 
were absent in the first manifestation.
Among the various involved sites, the most common 
was the spinal cord (n=22, 35.5%), followed by 
combined involvement of the optic nerve and spinal cord 
(n=16, 25.8%; Table 3). Table 4 compares the clinical 
features of the three MS subtypes. The frequency of 
female patients tended to be higher for those with 
opticospinal MS than for those with the spinal form of 
MS, but not higher than for those with the conventional Lee SS, et al. Clinical Features of Multiple Sclerosis in Korea
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Age range (years)
Sex
Total
Males (n) Females (n)
<20 2 5 7
21-30 2 13 15
31-40 14 8 22
41-50 3 5 8
>51- 4 6 10
Total 25 37 62
Table 2. Initial neurological symptoms
Initial symptoms Number (%)
Visual acuity change 21 (33.9)
Motor weakness 28 (45.1)
Sensory disturbances 6 (9.7)
Brainstem involvement 7 (11.3)
INO 3 (4.8)
Swallowing difficulty 1 (1.6)
Dizziness 2 (3.2)
Dysarthria 1 (1.6)
INO; internuclear ophthalmoplegia
Table 3. Involved sites
Involved site Number (%)
Single site
Spinal cord 22 (35.5)
Cerebrum 10 (16.1)
Multiple sites
Optic nerve + spinal cord 16 (25.8)
Spinal cord + cerebrum  9 (14.5)
Optic nerve + spinal cord + cerebrum 5 (8.1)
Table 1. Distribution of sex and age of onset
Figure 1. Clinical courses of MS: RRMS; relapsing-remitting 
MS, SPMS; secondary progressive MS, PRMS; progressive 
relapsing MS, NPNR; nonprogressing and nonrelapsing MS
form of MS. There were more male patients than female 
patients with spinal MS. The age at onset was 
significantly higher in spinal MS than in opticospinal 
and conventional MS; however, the age at onset was 
similar for opticospinal MS and conventional MS. The 
number of exacerbations among the 62 patients was 
3.8±2.6. The number of exacerbations tended to be 
higher for opticospinal MS than for spinal and 
conventional MS, but the difference did not reach 
statistical significance. The interval from the first 
symptom to the second event or first exacerbation was 
35.6±71.1 months (median 9.0 months, range 1-360 
months). Opticospinal MS was associated with the 
shortest interval from the first symptom to the first 
exacerbation among the three subtypes.
Patients could be subdivided into four groups 
according to the clinical course of their disease: 
relapsing-remitting MS (n=46, 74.2%), secondary 
progressive MS (n=9, 14.5%), progressive-relapsing 
MS (n=2, 3.2%), and nonprogressing and non-
relapsing (monophasic) MS (n=5, 8.1%; Fig. 1). A 
situation where relapsing-remitting MS evolves into 
the course progressing slowly between discrete attacks 
or instead of the attack is known as secondary 
progressive MS. The follow-up period was 100.7±96.6 
months for relapsing-remitting MS and 49.2±27.6 
months for secondary progressive MS (p=0.12).
Bain MRI scans exhibited high-signal-intensity lesions 
in T2-weighted images in 20 out of 37 patients (54.1%), 
but only 1 patient exhibited characteristic numerous and 
confluent multiple white-matter lesions, even some time 
after the onset of MS. Furthermore, on MRI the 
cerebellar hemispheric lesions were only seen in one 
patient. Regarding the MRI characteristics of mye-
lopathy, this study revealed a relatively longer spinal- 
segment involvement than the two vertebral segments 
(72.5% vs 27.5%; Table 5). The segments that exhibited 
an abnormal intensity tended to be longer in spinal MS 
than in opticospinal and conventional MS, although the 
difference did not reach statistical significance. The 
thoracic cord was more frequently involved than the 
cervical cord.
Only 3 out of 28 patients had a pleocytosis of more 
than 50 cells/μl in the CSF. The frequency of the Journal of Clinical Neurology: Vol. 2, No. 4, 2006
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Opticospinal MS
(n=16)
Spinal MS
(n=22)
Conventional MS
(n=24)
p 
Sex ratio (female/male) 2.2 0.6 3.0 0.02
Age at onset (years) 30.0±10.2 41.6±13.9 32.8±12.8 0.01
Number of exacerbations 4.6±2.2 3.3±2.4 3.9±2.9 0.74
Interval of exacerbation (months) 23.6±24.1 39.3±78.3 40.3±85.5 0.31
Clinical course 0.08
RRMS(%) 13(81.3) 19(86.4) 14(58.3)
SPMS(%) 3(18.8) 1(4.5) 5(20.8)
NPNR(%) 2(9.1) 3(12.5)
PRMS(%) 2(8.3)
RRMS; relapsing-remitting MS, SPMS; secondary progressive MS, NPNR; nonprogressing and nonrelapsing MS, PRMS; progressive 
relapsing MS
Table 5. Comparison of the laboratory findings between opticospinal, spinal, and conventional forms of MS
Opticospinal MS
(n=16)
Spinal MS
(n=22)
Conventional MS
(n=24)
p 
CSF  OCB(%)  0/12 (0%)  5/17 (29.4%)  6/19 (31.6%) 0.09
IgG index(%)   4/8 (50%)  6/10 (60%)   3/7 (42.9%) 0.64
MBP(%)   2/5 (40.0%)   2/7 (28.6%)   1/5 (20.0%) 0.78
Spinal cord MRI
Length (no. of segments) 4.5±2.4 5.3±2.9 3.6±1.9 0.16
    > 2(%)  8/10 (80.0%) 11/18 (61.1%) 10/12 (83.3%) 0.34
  Location  C(%)  4/10 (40.0%)  6/20 (30.0%)  3/12 (25.0%) 0.30
           C+T(%)  1/10 (10.0%)  1/20 (5.0%)  4/12 (33.3%)
           T(%)  5/10 (50.0%) 11/20 (55.0%)  5/12 (41.7%)
           Atrophy  2/20 (10.0%)
Brain MRI abnormality   2/7 (28.6%)  0/11 (0.0%) 18/19 (94.7%) 0.00
Abnormal EP 
  VEP(%) 10/11 (90.9%)  4/16 (25.0%) 15/18 (83.3%) 0.00
  BAEP(%)  1/11 (9.1%)  3/13 (23.1%)  1/17 (5.9%) 0.34
  SEP(%)  9/11 (81.8%)  9/16 (56.3%) 10/19 (52.6%) 0.26
OCB; oligoclonal bands, MBP; myelin basic protein,  C; cervical, T; thoracic, EP; evoked potentials, VEP; visual evoked potentials, 
BAEP; brainstem evoked potentials, SEP; somatosensory evoked potentials 
Table 4. Comparison of the clinical findings between opticospinal, spinal and conventional forms of MS
presence of oligoclonal IgG bands during the entire 
clinical follow-up period in patients with any form of 
MS was very low (11 out of 48 patients, 22.9%; 
Table 5). The IgG index was obtained in 25 patients by 
measuring albumin and gamma globulin in both the 
serum and CSF.
2 IgG indices of more than 0.7 were 
found in 13 patients (52.0%), and a positive response for 
myelin basic protein was detected in only 5 patients 
(Table 5). 
Abnormal visual evoked potentials, consisting of 
delayed but well-preserved P100 waves, were recorded 
in 29 patients (64.4%), whereas the frequency of 
abnormal brain stem evoked potentials was extremely 
low (n=5, 12.2%). The rate of abnormalities in 
somatosensory evoked potentials in the patients with 
myelopathy was relatively high (n=28, 60.9%; Table 
5).Lee SS, et al. Clinical Features of Multiple Sclerosis in Korea
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DISCUSSION
This is the first multiple-hospital-based data analysis 
of MS patients in central Korea. There are some reports 
on the various characteristics in Asian- and Western-type 
MS.
3-5 We found several typical clinical features of 
MS among our Korean patients: (1) a frequent 
relapsing-remitting course, (2) selective clinical in-
volvement of both the optic nerve and the spinal 
cord, and (3) fewer lesions on T2-weighted brain MRI 
images. 
Considering the involved site, the most outstanding 
finding regarding Korean MS is that involvement of the 
optic nerve or spinal cord there is more common than 
that of the cerebrum or cerebellum. The most frequent 
site of single lesions was the spinal cord. Accordingly, 
the most common first symptoms were related to 
myelopathy. The symptoms of myelopathy were noted 
over the entire clinical follow-up period in 84% of our 
patients. Although the motor weakness and sensory 
disturbances observed were not attributable entirely to 
myelopathy, symptoms of conditions other than optic 
neuropathy and myelopathy were uncommon.
9 The 
proportion of patients with opticospinal MS (16 patients, 
25.8%) is similar to that reported for other Asian 
countries.
4,5  The sex ratio (females/males) of our patients 
was 1.48, which is lower than those in other reported 
studies involving other Asians and Westerners. A higher 
female to male ratio and a higher age at onset was 
observed for the opticospinal form compared with the 
conventional form among Japanese MS patients.
4,5 
However, these unique findings were not found in our 
patients. The frequency of male patients was higher for 
spinal MS than for the other types (p=0.02). One of the 
three hospitals from which we gathered data has a center 
for spinal cord disease. The patients recruited from that 
hospital had more spinal or opticospinal MS than those 
from the other two hospitals. In addition, more male 
patients were recruited from that hospital. This will have 
affected the sex ratio and age at onset.
The age at onset was higher for spinal MS than for 
the other two types. The few old patients with 
conventional MS in our cohort might also have skewed 
the mean age at onset in that group and for the entire 
cohort. Given the long-term course of MS, it is 
sometimes difficult to determine when the first symptom 
appears. In cases for which there were no medical 
records, we had to rely upon the memory of patients. 
These factors need to be taken into consideration when 
evaluating symptom onset and relapse. The number of 
exacerbations tended to be higher for opticospinal MS 
than for spinal and conventional MS. However, the 
difference regarding the number of exacerbations among 
the three MS forms did not reach statistical significance. 
Regarding the clinical course, the majority of our 
patients had relapsing-remitting MS. It appears likely 
that patients with relapsing disease visited a hospital 
more frequently than those with progressive forms of 
MS. We assume that a longer observation period in 
relapsing-remitting MS could exclude the possibility of 
developing the secondary progressive form in later 
stages. The interval from first symptom to the first 
relapse was 35.6±71.1 months, and ranged greatly from 
1 month to 30 years; the median value was just 9 
months. The very long interval observed for a few 
patients makes the mean value longer than expected. 
Therefore, it appears unlikely that some patients in the 
spinal MS group will develop involvement of either the 
optic nerve or other CNS sites. The majority of Western 
patients with relapsing disease exhibit Expanded 
Disability Status Scale (EDSS) scores of 4.0 or less 
(self-sustained and fully ambulatory), whereas the 
majority of patients with progressive disease types have 
EDSS scores of 6.0 or greater (at least unilateral 
assistance for walking).
10  These findings emphasize the 
importance of early diagnosis and intervention in 
patients with relapsing disease to slow or prevent the 
accumulation of physical disability associated with 
frequent relapsing or progressive types of this disease.
Regarding the MRI characteristic of myelopathy, this 
study revealed a relatively longer spinal segment 
involvement than the two vertebral segments (72.5% vs 
27.5%). The thoracic spinal cord was more frequently 
involved than the cervical cord. These observations have 
also been made in other Asian and Korean MS 
patients,
4,6,11  but they are uncommon in white people.
12 
Consensus criteria are needed for defining myelopathy in Journal of Clinical Neurology: Vol. 2, No. 4, 2006
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MS patients, because many Korean MS patients with 
myelopathy exhibit no compatible MRI lesion in the 
spinal cord (according to the diagnostic criteria of 
McDonald et al.)
8,11
One of the clinically definite MS criteria put forward 
by Poser et al. requires evidence from a history of two 
episodes, signs of one lesion on examination, and 
evidence from evoked responses or MRI of other lesions 
(A2). Although 20 out of 37 patients who underwent a 
brain MRI exhibited the high-signal-intensity lesions on 
T2 weighted images (54.1%), it is not always easy to 
differentiate true MS-specific lesions from these 
findings. Furthermore, the strict criteria of McDonald et 
al. for positive MRI results are seldom satisfied. 
Clinicians use evoked potentials in MS suspects to 
identify clinically unsuspected lesions. However, only 
three MS suspects in our study were reclassified into the 
definite MS category as a result of identification of 
clinically silent lesions based on evoked potentials. In 
this regard, brain MRI and evoked potentials are useful 
in only a few cases for identifying patients at risk of 
developing clinically definite MS. Otherwise, the rate of 
abnormal visual evoked potentials or somatosensory 
evoked potentials was relatively high in the patients with 
optic neuropathy or myelopathy. As a result, the 
diagnostic value of evoked potentials and MRI for 
detecting unsuspected MS lesions was very limited in 
Korean patients. This might be one of the reasons why 
in this study there were very few patients with clinically 
definite MS (A2) as defined by the criteria of Poser et 
al. A MS study involving Japanese patients also found 
a small number of laboratory-supported definite MS 
patients compared with a large number of clinically 
definite MS patients.
9
Only 3 out of 28 patients had a pleocytosis of more 
than 50 cells/μl in the CSF. Although the pleocytosis 
was noted in more than 10% of our patients, as for the 
Japanese patients,
4 there were too few such patients to 
allow statistical analysis. The frequency of the presence 
of IgG oligoclonal bands was lower for opticospinal MS 
than for conventional or spinal MS. The proportion of 
elevated IgG indices did not differ among opticospinal, 
spinal, and conventional MS. Moreover, there was no 
statistically significant difference in the frequency of 
either an increased IgG index or the presence of 
oligoclonal bands among the three types of MS. We 
could not compare the value of IgG index with those of 
other studies, because the criteria for elevated IgG index 
have varied between studies. However, the frequency of 
an increased IgG index or the presence of oligoclonal 
bands in any type of MS was lower among Korean 
patients than among white people. These findings might 
be strongly associated with the low rates of periven-
tricular and callosal MRI lesions in our patients.
13 
However, there has been a report of Korean MS patients 
with a high frequency of the presence of CSF 
oligoclonal bands.
6  Low positive rates of CSF 
oligoclonal bands in MS could explain why there are 
fewer patients with laboratory-supported definite MS 
than with clinically definite MS. Given the strict positive 
criteria for brain MRI abnormalities defined by 
McDonald et al.,
8  the paucity of typical multiple cerebral 
and cerebellar white matter lesions on brain MRI in 
Korean MS patients would reduce further the usefulness 
of brain MRI as a diagnostic tool for detecting 
asymptomatic lesions. Cerebellar symptoms are also 
described only rarely in Japanese patients.
9  These 
limitations of brain MRI and CSF studies hinder the 
ability of Korean neurologists to make early diagnoses 
of definite MS.
Whilst we did not perform a genetic study, another 
unique finding in our Korean patients was the absence 
of the familial aggregation of MS, which in contrast is 
well established in white people.
2
A serum autoantibody marker of neuromyelitis optica 
(NMO-IgG) was recently found to be useful for 
differentiating neuromyelitis optica from MS. It was 
asserted that neuromyelitis optica is not MS, and that 
Asian opticospinal MS is the same as neuromyelitis 
optica.
14  However, it is too early to conclude whether or 
not opticospinal MS is MS or a variant of MS, at least 
in Asians.
15  Further strict diagnostic criteria for each 
subtype and serological studies involving more Asian 
MS patients are needed to resolve this issue. 
In summary, the results of this study strongly suggest 
that the clinical features of MS in Korea are in part 
similar to those in other Asian countries, where MS has 
a low prevalence. Future studies are needed, including Lee SS, et al. Clinical Features of Multiple Sclerosis in Korea
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an examination of immunogenetic characteristics and a 
long-term clinical follow-up based on the objective 
disability scoring system in Korean MS patients. It will 
remain difficult to perform a cross-sectional epide-
miologic study in the near future because of the high 
migration rate and low prevalence of MS in Korea.
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